Volume 34, 10 October 2003 | 10/2003 |
SPOT ON | |
Do we need drug representatives? | |
THERAPIES FROM A CRITICAL VIEW POINT | |
Acute coronary syndrome: Early catheter intervention or prolonged antithrombotic pretreatment? | |
NEW ON THE MARKET | |
TNF- blocker adalimumab (HUMIRA) to treat rheumatoid arthritis | |
REVIEW | |
Treatment of hyperhidrosis: Botulinum toxin type A etc. | |
a-t READERS' QUESTIONS AND COMMENTS | |
Pneumococcal vaccination - for whom? | |
QUACKERY | |
Indian herbal tea against cancer? | |
IN BRIEF | |
Influenza vaccines 2003/2004 | |
CURRENT ADR NETWORK REPORT | |
Hazardous drop in blood pressure due to alfuzosin (e.g. URION) | |
© arznei-telegramm 10/2003 | ||